This page is part of the Pharmaceutical Clinical Trial Protocols (v1.0.0-ballot: STU 1 Ballot 1) based on FHIR (HL7® FHIR® Standard) v6.0.0. No current official version has been published yet. For a full list of available versions, see the Directory of published versions
Official URL: http://hl7.org/fhir/uv/pharmaceutical-research-protocol/ValueSet/m11-identifier-type-vs | Version: 1.0.0-ballot | |||
Standards status: Trial-use | Maturity Level: 1 | Computable Name: M11IdentifierType_VS |
Identification of the type of identifier.
References
http://ncicb.nci.nih.gov/xml/owl/EVS/Thesaurus.owl
Code | Display |
C132351 | Sponsor Protocol Identifier |
C218672 | Original Protocol Indicator |
C218477 | Amendment Identifier |
C218684 | EU CT Number |
C218685 | FDA IND Number |
C218686 | IDE Number |
C218687 | jRCT Number |
C172240 | NCT Number |
C218688 | NMPA IND Number |
C218689 | WHO/UTN Number |
C218690 | Other Regulatory or Clinical Trial Identifier |
This value set contains 0 concepts
Code | System | Display (en-US) |
Explanation of the columns that may appear on this page:
Level | A few code lists that FHIR defines are hierarchical - each code is assigned a level. In this scheme, some codes are under other codes, and imply that the code they are under also applies |
System | The source of the definition of the code (when the value set draws in codes defined elsewhere) |
Code | The code (used as the code in the resource instance) |
Display | The display (used in the display element of a Coding). If there is no display, implementers should not simply display the code, but map the concept into their application |
Definition | An explanation of the meaning of the concept |
Comments | Additional notes about how to use the code |